author-photo

Antonio Llombart-Cussac

Universidad Católica de Valencia San Vicente Mártir

6

Papers

30

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase II trial.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (3)
The role of CDK4/6 inhibitors in early breast cancer.

2021 The Breast
Show All
- Source
- Cite
- Save
Citations (2)
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019.

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (25)